source
- Abbott reports 30‑day success in Tectonic trial of SonicForce coronary IVL systemAbbott announced that its investigational SonicForce Coronary IVL system achieved positive 30‑day outcomes in the Tectonic trial involving patients with severely calcified coronary artery disease.…
- Advanced analytics enable up to 12% cut in control animal use while keeping study rigorThe control group is a cornerstone of nonclinical safety studies, providing the baseline needed to separate a drug’s effects from normal biological variation. Researchers are now applying virtual…